Cardiovascular Disease (CVD) is one of the leading causes of death in the United States. The goal of the Cardiovascular Health Improvement Project (CHIP) is to learn more about individuals with aortic diseases and other cardiovascular-related conditions through collecting and analyzing blood and clinical data from patients.
By doing this, we can learn more about the genetics behind CVD, help clinicians provide the best care for their patients, and lower the incidence of CVD.
What is CHIP ?
CHIP is a collection (or “biorepository”) of DNA, plasma, serum, and aortic tissue samples as well as an extensive clinical database of medical and family history information.
Our Patient Population
When we began biobanking in the Fall of 2013, we focused exclusively on patients with aortic disease diagnoses. Since then we have gone through several expansions in terms of the patient populations we enroll. As of 2016, we have expanded into heart failure, arrhythmia, and dyslipidemia.
We are currently enrolling patients who have one or more of the following diagnoses or demographics:
- Aortic disease
- Connective tissue disorders
- Bicuspid aortic valve
- Heart Failure
Specific Aims of the Project
- Facilitate scientific discovery by providing researchers and faculty with biospecimens and clinical information.
- Establish a biorepository of DNA, cell pellet, serum, plasma, and aortic tissue.
- Establish a comprehensive database.
The CHIP Study Team
For information about the study team, visit the CHIP Study Team page.
Participate in the Cardiovascular Health Improvement Project
We enroll patients from various clinics within the UMHS Frankel Cardiovascular Center, as well as via referral to our facility. To learn more about how you can participate in the CHIP study, call us at 734-232-4779 or visit our CHIP Participants FAQ page.